Thomasian Harry Jr. 4
4 · PRECIGEN, INC. · Filed May 27, 2026
Research Summary
AI-generated summary of this filing
Precigen (PGEN) CFO Harry Thomasian Receives 87,500 Shares
What Happened
- Harry Thomasian Jr., Chief Financial Officer of Precigen (PGEN), reported the conversion/vesting of 87,500 restricted stock units (RSUs) into shares on May 23, 2026. The Form 4 shows an acquisition of 87,500 shares (exercise/conversion, code M) with acquisition price N/A.
- The filing also shows a simultaneous disposition of 87,500 shares at $0.00 (also coded as M, listed as derivative disposition with $0 total proceeds). The filing does not report cash proceeds for the disposition.
Key Details
- Transaction date: 2026-05-23; Form 4 filed: 2026-05-27 (filed four days after the reported transaction).
- Acquisition: 87,500 shares (exercise/conversion of derivative) — acquisition price N/A.
- Disposition: 87,500 shares (exercise/conversion of derivative) — price $0.00; proceeds $0.
- Footnotes:
- F1: Each RSU equals a contingent right to one share of Precigen common stock.
- F2: The 87,500 shares represent 50% of RSUs granted on June 26, 2025 that vested on May 23, 2026; the remaining RSUs vest in equal quarterly installments over the next three years.
- Shares owned after the transaction: not provided in the information supplied here.
- Timeliness: The report was filed four days after the transaction date; check the official Form 4 for any late-file disclosure.
Context
- For RSU conversions, it's common for filings to show both the shares issued on vesting and an equal number of shares reported as withheld or disposed to cover taxes or other obligations. The Form 4 here lists a matching disposition at $0.00; the filing does not explicitly state the reason for the disposal.
- This was not an open-market purchase or sale for cash; it reflects award vesting/conversion activity (an award realization event), not a market-directed trade.
Insider Transaction Report
Form 4
PRECIGEN, INC.PGEN
Thomasian Harry Jr.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-05-23+87,500→ 596,419 total - Exercise/Conversion
Restricted Stock Units
[F1][F2]2026-05-23−87,500→ 87,500 total→ Common Stock (87,500 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
- [F2]Represents 50% of the RSUs granted on June 26, 2025 that vested on May 23, 2026. The remaining RSUs will vest in equal quarterly installments for three years thereafter.
Signature
/s/ Harry Thomasian, Jr., by Donald P. Lehr, as attorney-in-fact|2026-05-27